Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Phase II study of Bevacizumab and Erlotinib in previously untreated hepatocellular carcinoma (HCC)

Govindarajan R, Siegel E, Makhoul I, Williamson S. Phase II study of Bevacizumab and Erlotinib in previously untreated hepatocellular carcinoma (HCC). 2010.


collapse authors with profiles